Objectives: To study the pathologic spectrum of kidney diseases in patients with hepatitis C virus infection (HCV+).
Methods: Native kidney biopsy specimens in HCV+ patients were reviewed.
Results: A total of 9,836 native kidney biopsy specimens were evaluated from January 2007 to December 2016, of which 273 (2.